Literatur
-
1
Enck P, Benedetti F, Schedlowski M.
New insights into the placebo and nocebo responses.
Neuron.
2008;
59
195-206
-
2
Moseley J B, O'Malley K, Petersen N J. et al .
A controlled trial of arthroscopic surgery for osteoarthritis of the knee.
N Engl J Med.
2002;
347
81-88
-
3
Enck P, Klosterhalfen S, Zipfel S.
Acupuncture, psyche and the placebo response.
Auton Neurosci.
2010;
157
68-73
-
4
Kaptchuk T J, Stason W B, Davis R B. et al .
Sham device v inert pill: randomised controlled trial of two placebo treatments.
BMJ.
2006;
332
391-397
-
5
Khan A, Bomminayuni E P, Bhat A. et al .
Are the colors and shapes of current psychotropics designed to maximize the placebo response?.
Psychopharmacology (Berl).
2010;
211
113-122
-
6
Hróbjartsson A, Gøtzsche P C.
Placebo interventions for all clinical conditions.
Cochrane Database Syst Rev
2010;
(1)
CD003974
-
7
Chey W D, Chey W Y, Heath A T. et al .
Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
Am J Gastroenterol.
2004;
99
2185-2203
-
8
Klinger R, Soost S, Flor H. et al .
Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin.
Pain.
2007;
128
31-39
-
9
Vits S, Cesko E, Enck P. et al .
Behavioural conditioning as the mediator of placebo responses in the immune system.
Philos Trans R Soc Lond B Biol Sci.
2011;
366
1799-1807
-
10
Klosterhalfen S, Rüttgers A, Krumrey E. et al .
Pavlovian conditioning of taste aversion using a motion sickness paradigm.
Psychosom Med.
2000;
62
671-677
-
11
Pollo A, Carlino E, Benedetti F.
The top-down influence of ergogenic placebos on muscle work and fatigue.
Eur J Neurosci.
2008;
28
379-388
-
12
Kunz M, Rainville P, Lautenbacher S.
Operant conditioning of facial displays of pain.
Psychosom Med.
2011;
73
422-431
-
13
Colloca L, Benedetti F.
Placebo analgesia induced by social observational learning.
Pain.
2009;
144
28-34
-
14
Tracey I.
Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.
Nat Med.
2010;
16
1277-1283
-
15
Bingel U, Wanigasekera V, Wiech K. et al .
The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil.
Sci Transl Med.
2011;
3
70ra14
-
16
Benedetti F, Pollo A, Lopiano L. et al .
Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo / nocebo responses.
J Neurosci.
2003;
23
4315-4323
-
17
Moerman D E, Jonas W B.
Deconstructing the placebo effect and finding the meaning response.
Ann Intern Med.
2002;
136
471-476
-
18
Allan L G, Siegel S.
A signal detection theory analysis of the placebo effect.
Eval Health Prof.
2002;
25
410-420
-
19
Miller F G, Colloca L.
Semiotics and the placebo effect.
Perspect Biol Med.
2010;
53
509-516
-
20
Colloca L, Benedetti F.
How prior experience shapes placebo analgesia.
Pain.
2006;
124
126-133
-
21
Stockhorst U, Wiener J A, Klosterhalfen S. et al .
Effects of overshadowing on conditioned nausea in cancer patients: an experimental study.
Physiol Behav.
1998;
64
743-753
-
22
Rief W, Nestoriuc Y, Lilienfeld-Toal A von. et al .
Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.
Drug Saf.
2009;
32
1041-1056
-
23
Amanzio M, Corazzini L L, Vase L. et al .
A systematic review of adverse events in placebo groups of anti-migraine clinical trials.
Pain.
2009;
146
261-269
-
24
Häuser W, Bartram C, Bartram-Wunn E. et al .
Systematic review: Adverse events attributable to nocebo in randomised controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy.
Clin J Pain.
2011;
152
1709-1717
-
25
Kaptchuk T J, Friedlander E, Kelley J M. et al .
Placebos without deception: a randomized controlled trial in irritable bowel syndrome.
PLoS One.
2010;
5
e15591
-
26
Su C, Lichtenstein G R, Krok K. et al .
A meta-analysis of the placebo response rates of remission and response in clinical trials of active Crohn’s disease.
Gastroenterology.
2004;
126
1257-1269
-
27
Kaptchuk T J, Kelley J M, Conboy L A. et al .
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.
BMJ.
2008;
336
999-1003
-
28
Kelley J M, Lembo A J, Ablon J S. et al .
Patient and practitioner influences on the placebo effect in irritable bowel syndrome.
Psychosom Med.
2009;
71
789-797
-
29
Levine J D, Gordon N C, Fields H L.
The mechanism of placebo analgesia.
Lancet.
1978;
2
654-657
-
30
Finniss D G, Kaptchuk T J, Miller F. et al .
Placebo effects: biological, clinical and ethical advances.
Lancet.
2010;
375
686-695
-
31
Enck P, Klosterhalfen S.
The story of O – Is oxytocin the mediator of the placebo response?.
Neurogastroenterol Motil.
2009;
21
347-350
-
32
Furmark T, Appel L, Henningsson S. et al .
A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.
J Neurosci.
2008;
28
13 066-13 074
-
33
Leuchter A F, McCracken J T, Hunter A M. et al .
Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.
J Clin Psychopharmacol.
2009;
29
372-377
-
34
Kaptchuk T J, Kelley J M, Deykin A. et al .
Do „placebo responders“ exist?.
Contemp Clin Trials.
2008;
29
587-595
-
35
Geers A L, Helfer S G, Kosbab K. et al .
Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response.
J Psychosom Res.
2005;
58
121-127
-
36
Weimer K, Enck P, Klosterhalfen S.
Geschlechtseffekte bei der Placeboresponse.
Z Med Psychol.
19;
2010
146-153
-
37
Klosterhalfen S, Kellermann S, Braun S. et al .
Gender and the nocebo response following conditioning and expectancy.
J Psychosom Res.
2009;
66
323-328
-
38
Parellada M, Moreno C, Moreno M. et al .
Placebo effect in child and adolescent psychiatric trials.
Eur Neuropsychopharmacol.
2012;
[im Druck]
-
39
Rutherford B R, Sneed J R, Tandler J M. et al .
Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.
J Am Acad Child Adolesc Psychiatry.
2011;
50
782-795
-
40
Enck P, Klosterhalfen S, Zipfel S.
Novel study designs to investigate the placebo response.
MC Med Res Methodol.
2011;
11
90
-
41
Enck P, Klosterhalfen S, Weimer K. et al .
The placebo response in clinical trials: more questions than answers.
Philos Trans R Soc Lond B Biol Sci.
2011;
366
1889-1895
-
42
Petrovic P, Kalso E, Petersson K M. et al .
A prefrontal non-opioid mechanism in placebo analgesia.
Pain.
2010;
150
59-65
-
43
Rief W, Bingel U, Schedlowski M. et al .
Mechanisms involved in placebo and nocebo responses and implications for drug trials.
Clin Pharmacol Ther.
90;
2011
722-726
-
44
Vase L, Riley 3rd J L, Price D D.
A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.
Pain.
2002;
99
443-452
-
45
Hegerl U, Mergl R.
The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences.
J Psychopharmacol.
2010;
24
445-448
-
46
Fässler M, Meissner K, Schneider A. et al .
Frequency and circumstances of placebo use in clinical practice – a systematic review of empirical studies.
BMC Medicine.
2010;
8
15
Prof. Dr. Dipl.-Psych. Paul Enck
Abt. für Psychosomatische Medizin und Psychotherapie, Medizinische Universitätsklinik Tübingen
Frondsbergstraße 23
72076 Tübingen
eMail: paul.enck@uni-tuebingen.de
